Cell cycle-dependent control of polarised development by a cyclin-dependent kinase-like protein in the Fucus zygote

被引:0
|
作者
Corellou, F
Brownlee, C
Kloareg, B
Bouget, FY [1 ]
机构
[1] CNRS, Biol Stn, UMR 1931, F-29680 Roscoff, France
[2] Lab Goemar, F-29680 Roscoff, France
[3] Marine Biol Assoc United Kingdom Lab, Plymouth PL1 2PB, Devon, England
来源
DEVELOPMENT | 2001年 / 128卷 / 21期
关键词
Fucus zygote; polarisation; morphogenesis; cell cycle; CDK;
D O I
暂无
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Although iterative development can be uncoupled from morphogenesis in plant organs, the relationship between the cell cycle and developmental events is not well established in embryos. Zygotes of fucoid algae, including Fucus and Pelvetia are particularly well suited for studying the interaction(s) between cell cycle progression and the early morphogenetic events, as the establishment of polarity and its morphogenetic expression, i.e. germination, and the first cell cycle are concomitant. We have previously demonstrated that, in Fucus zygotes, various aspects of cell cycle progression are tightly controlled by cyclin-dependent kinase (CDK)-like proteins, including two PSTAIRE CDK-like proteins, p34 and p32, which are synthesised after fertilisation. We show that specific inhibition of CDK-like proteins, either with purine derivatives such as olomoucine and amino-purvalanol or by microinjection of the CDK inhibitor p21(cip1), prevents germination and cell division. Whereas direct inhibition of DNA replication by aphidicolin did not affect polarised development, olomoucine, which has previously been shown to prevent entry in S phase, and other purine derivatives also inhibited photopolarisation. Early microinjection of a monoclonal anti-PSTAIRE antibody also prevented germination and cell division. Only p34 had affinity for amino-purvalanol, suggesting that among PSTAIRE CDKs, this protein is the main target of purine derivatives. Models to account for the simultaneous control of early cell cycle progression and polarisation are proposed.
引用
下载
收藏
页码:4383 / 4392
页数:10
相关论文
共 50 条
  • [21] Critical Determinants of Substrate Recognition by Cyclin-Dependent Kinase-like 5 (CDKL5)
    Katayama, Syouichi
    Sueyoshi, Noriyuki
    Kameshita, Isamu
    BIOCHEMISTRY, 2015, 54 (19) : 2975 - 2987
  • [22] Kinase activity of cyclin-dependent kinase complexes in the cell cycle of chlorococcal algae
    Hendrychová, J
    Vítová, M
    Eízková, M
    Zachleder, V
    FEBS JOURNAL, 2005, 272 : 456 - 456
  • [23] Cell Cycle Regulation by Chlamydomonas Cyclin-Dependent Protein Kinases
    Bertoni, Gregory
    PLANT CELL, 2018, 30 (02): : 271 - 271
  • [24] An overview of ganaxolone as a treatment for seizures associated with cyclin-dependent kinase-like 5 deficiency disorder
    Gould, Alfie
    Amin, Sam
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2024, 24 (10) : 945 - 951
  • [25] Neurobehavioral phenotype in cyclin-dependent kinase-like 5 syndrome: Case report and review of literature
    Posar, Annio
    Faggioli, Raffaella
    Visconti, Paola
    JOURNAL OF PEDIATRIC NEUROSCIENCES, 2015, 10 (03) : 258 - 260
  • [26] Cyclin-Dependent Kinase-Like Function Is Shared by the Beta- and Gamma- Subset of the Conserved Herpesvirus Protein Kinases
    Kuny, Chad V.
    Chinchilla, Karen
    Culbertson, Michael R.
    Kalejta, Robert F.
    PLOS PATHOGENS, 2010, 6 (09)
  • [27] The effect of the cyclin-dependent kinase inhibitor olomoucine on cell cycle kinetics
    Schutte, B
    Nieland, L
    vanEngeland, M
    Henfling, MER
    Meijer, L
    Ramaekers, FCS
    EXPERIMENTAL CELL RESEARCH, 1997, 236 (01) : 4 - 15
  • [28] The Cyclin-dependent kinase 1: more than a cell cycle regulator
    Massacci, Giorgia
    Perfetto, Livia
    Sacco, Francesca
    BRITISH JOURNAL OF CANCER, 2023, 129 (11) : 1707 - 1716
  • [29] Cyclin-dependent kinase inhibitors: Useful targets in cell cycle regulation
    Sielecki, TM
    Boylan, JF
    Benfield, PA
    Trainor, GL
    JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (01) : 1 - 18
  • [30] The Cyclin-dependent kinase 1: more than a cell cycle regulator
    Giorgia Massacci
    Livia Perfetto
    Francesca Sacco
    British Journal of Cancer, 2023, 129 : 1707 - 1716